Two drugmakers to be made public by FTC

Korea’s antitrust regulator announced Wednesday that Myungmoon Pharmaceutical Co. was found to have provided 3.6 billion won to doctors and hospitals in return for prescribing, purchasing or recommending their products, as a result of its probe since October 2010.

The Fair Trade Commission is expected to make public a list of other pharmaceutical companies, such as Reyon and Keunwha Pharmace...